ACHN Stock UPDATES Achillion Pharmaceuticals (ACHN) 12.67 09/11/2014

New Post Public Reply Private Reply Replies (0) Message Board

Sep 11, 2014 at 9:14 PM

Achillion Pharmaceuticals (ACHN) 12.67 $ACHN

Jim Cramer's 'Mad Money' Recap: Enjoy This Bull Market While It Lasts
at The Street - 1 hr 27 mins ago
As long as it's here, good things are happening every day, Cramer says.

Can the Rally in Achillion (ACHN) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 10, 9:58AM CDT
Can the Rally in Achillion (ACHN) Shares Continue?

Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications
PR Newswire - Tue Sep 09, 7:35AM CDT
Today, Analysts Review released its research reports regarding Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN), Deere & Company (NYSE: DE), Honeywell International Inc. (NYSE: HON), Lockheed Martin Corporation (NYSE: LMT) and L-3 Communications Holdings Inc. (NYSE: LLL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6311-100free.

Most active Nasdaq-traded stocks
AP - Fri Sep 05, 2:45PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:

Nasdaq stocks posting largest percentage decreases
AP - Fri Sep 05, 2:45PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte
at The Street - Fri Sep 05, 7:55AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.

Why Achillion Pharmaceuticals (ACHN) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 7:33AM CDT
Achillion Pharmaceuticals belongs to the Medical industry, is a decent pick as it witnessed solid earnings estimate revision activity with a favorable Zacks Industry Rank.

Market Maker Surveillance Report. GILD, GE, SLM, ACHN, WU, SREV, Bullishly Biased Price Friction For Wednesday, September 3rd 2014
M2 - Thu Sep 04, 10:02AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4918 companies with "abnormal" market making, 2306 companies with positive Friction Factors and 2830 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. GILEAD SCIENCES, INC. (NASDAQ:GILD), General Electric Co (NYSE:GE), SLM Corp (NASDAQ:SLM), Achillion Pharmaceuticals Inc (NASDAQ:ACHN), Western Union Co (NYSE:WU), SERVICESOURCE INTERNATIONAL INCORPORATED (NASDAQ:SREV). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

'Mad Money' Lightning Round: I'm Taking Verizon Over AT&T
at The Street - Wed Sep 03, 5:00AM CDT
Cramer prefers Dow Chemicals to FMC and MGM Resorts to Las Vegas Sands.

Jim Cramer's 'Mad Money' Recap: The 2012 Stock Market All Over Again
at The Street - Tue Sep 02, 6:49PM CDT
Investors are dumping the industrial and technology stocks in favor of anything domestic, including health care, transportation, restaurants and entertainment, Cramer says.

Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel
PR Newswire - Tue Sep 02, 7:55AM CDT
Today, Insiderslab.com revealed the latest insider trading research for Facebook (NASDAQ: FB), Plug Power (NASDAQ: PLUG), Achillion Pharmaceuticals (NASDAQ: ACHN), Apple (NASDAQ: AAPL), Twitter (NYSE: TWTR), and Intel (NASDAQ:INTC). US stock investors can access these reports through the links below, including stock performance, insider trading signals, and visual results.

Four biotech takeover targets?
at Investor's Business Daily - Fri Aug 29, 5:58PM CDT
Following the news that Roche (RHHBY) is acquiring InterMune (ITMN) for $8.3 bil, other takeover talk has started to stir, leading to speculation that Achillion Pharmaceuticals (ACHN), Intercept Pharmaceuticals (ICPT), Puma Biotechnology (PBYI) and...

4 Biotechs That Might Be Bought Soon
at Investor's Business Daily - Fri Aug 29, 10:53AM CDT
The recent announcement that Roche (RHHBY) will buy InterMune (ITMN) for $8.3 billion brought new life to M&A speculation in the biotech industry, which had been relatively neglected as the buzz focused on tax-inversion deals by biopharmaceutical...

Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Aug 27, 9:32AM CDT
Roche's agreement to acquire InterMune has raised hopes for more such deals in the biotech sector.

The Zacks Analyst Blog Highlights: Roche, InterMune, Achillion Pharmaceuticals, Puma Biotechnology and Intercept Pharmaceuticals
PR Newswire - Wed Aug 27, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Roche (OTC:RHHBY-Free Report), InterMune (Nasdaq:ITMN-Free Report), Achillion Pharmaceuticals (Nasdaq:ACHN-Free Report), Puma Biotechnology (NYSE

BYI-Free Report) and Intercept Pharmaceuticals (Nasdaq:ICPT-Free Report).

Achillion Pharmaceuticals (ACHN) Jumps: Stock Adds 9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:37AM CDT
Achillion Pharmaceuticals, Inc. (ACHN) was a big mover last session, as the company saw its shares rise 9% on the day.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PBM Transparency Rule: Game Changer for 136M Americans

Turning the Tide on Pharmacy Costs The world of pharmacy benefits is getting a long-overdue shake-up, courtesy of a new rule mandating transparency from the pharmacy benefit managers (PBMs). This ain't your everyday administrative tweak—it's a seismic shift for the 136 million Americans tied into employer-sponsored health plans. Thanks to the U.S. Department of Labor...

CopperWood Senior Living Revives Historic Campus

A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...

Sage Longboat Key Condos Battle Florida's Marine Climate

Building Resilience on Florida's Shores If you've ever had your eyes on some beachfront real estate down in Florida, you'd know it's not all sandy beaches and sunsets. It's a constant battle against the elements, my friends. The Sage Longboat Key condominiums in Sarasota have taken this challenge head-on with some serious innovation. The Condominium Dream Sitting pretty...

Evotec SE to Release Q3 Results: What to Expect

Anticipation Builds Around Evotec's Q3 2026 Results It's that time again when everyone's tightening their belts in anticipation of another earnings feed. On November 5, Evotec SE is dropping their results for the first nine months of this whirlwind year. Right out of Germany, Hamburg, they're gearing up for a webcast and conference call where all eyes, or should I say...

AGIBOT's Worken: A New Era in Robot Productivity

Measuring Productivity Goes Beyond Manufacturing Robots aren't just assembly-line tools anymore. In Shanghai, AGIBOT dropped a bombshell at their Innovation Day event: the introduction of Worken, a framework that turns the spotlight on robots' real-world task performance over mere numbers on a production line. Breaking Down Worken Worken, a mash-up of 'Work' and 'Token,'...

FirstEnergy Bolsters Support for Shelter Initiatives

FirstEnergy Foundation's Commitment Shines Bright Alright, here's the scoop. FirstEnergy Foundation isn't just about keeping the lights on anymore. They're throwing down $620,000 to tackle one hell of a tough nut—shelter and stability. This latest infusion spreads across five states, with ten nonprofit warriors in New Jersey alone locking in $120,000 of that pot for...

Chertova: From Intern to NECP Senior Analyst

Fast Lane Promotion for Chertova It's not every day you see a path from intern to senior analyst paved in just three years. But Anastasia Chertova has pulled off exactly that at New England Consulting Partners (NECP). From crunching numbers as an intern to headlining projects in front of the C-Suite, she's made quite the mark. The kind of trajectory most folks just...

Sobi Names Börje Ekholm as Chair Amid New Data

An Offbeat Choice for Chair? So, Sobi's gone and picked Börje Ekholm as the proposed Chair of their Board. Now, this might raise some eyebrows out there—Ekholm's no stranger to top roles, having steered the ship at Ericsson. The twist here is usually these Chair announcements hum along without much fanfare, but chuck in Ekholm and you get a bit of buzz—probably...

Max Stock Gears Up for Q3 Earnings Report Nov. 17

Max Stock's Q3 Earnings Anticipation Ah, it’s that time again—when we wait with bated breath for another round of quarterly earnings. Max Stock Ltd. (TASE: MAXO) is prepping to spill the beans on their third quarter 2026 performance, with a conference call scheduled for November 17. Big day? You bet. Who's Leading the Call? The brains behind the operation, CFO Paz Oz...

MSM's New Tool Tackles Label Errors with AI Insight

Nailing Label Precision in Real Time The label printing game just got a major new player. MSM Solutions is rolling out its PortalTrack Print Quality Inspection, and it's not just another tool in the shed—this thing's promising to cut down on label errors before they can bite. Imagine turning your good old industrial label printers into sharp-eyed inspectors, thanks to...